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1. INTRODUCTION
Lyme	 borreliosis	 (LB),	 a	 tick	 borne	 disease	
with	 the	 highest	 incidence	 in	 Europe	 and	 North	
America,	is	a	zoonosis;	Borrelia burgdorferi	sensu	
lato,	 the	 etiological	 agent,	 circulates	 between	
the	 Ixodes ricinus	 complex	 ticks	 and	 a	 variety	 of	
vertebrate	hosts	like	rodents,	squirrels	and	many	
species	 of	 birds.	 Natural	 hosts	 do	 not	 appear	
to	 develop	 clinical	 disease,	 while	 in	 humans	
LB	 presents	 with	 a	 variety	 of	 clinical	 signs	 and	
symptoms,	 affecting	 the	 skin,	 the	 heart,	 the	
nervous	and	musculoskeletal	systems,	and	several	
variations	in	the	course	of	the	disease.	LB	has	been	
first	described	in	1977	in	the	United	States,	though	
documentations	of	the	disease	exist	from	the	end	
of	 the	XIXth	 century	 in	Europe.	Recent	molecular	
studies	have	identified	sequence	of	B. burgdorferi 
DNA	in	“the	Iceman”	from	Tyrol,	a	5300	years	old	
human	body	discovered	in	the	Alps	(Keller	et al.,	
2011).	As	in	the	last	years	the	disease	has	become	
a	global	public	health	problem	and	the	interest	of	
medical	 personnel	 and	 researchers	 is	 constatly	
increasing,	 the	 review	 presents	 information	 on	
cellular	 and	molecular	 biology	 of	B. burgdorferi,	
interaction	with	the	human	host,	immune	response	
and	disease	pathogenesis.
2. THE ETIOLOGY OF LYME 
BORRELIOSIS
The	 first	 description	 of	 LB	 was	 made	 in	
Germany	 in	 1883	 as	 a	 chronic	 dermatological	
disease,	 named	 acrodermatitis	 chronica	
atrophicans	 (ACA).	 In	 1909,	 the	 Swedish	
dermatologist	 Afzelius	 described	 a	 slowly	
expanding	 cutaneous	 lesion,	 named	 erythema	
migrans	(EM)	and	in	1930	Hellerstrom	suggested	
a	relationship	between	tick	bite,	EM	and	disorders	
of	the	nervous	system.	In	1975-1976	in	the	town	
of	 Lyme,	USA,	 cases	of	 arthritis	 in	 children	were	
described,	 characterized	 by	 debut	 in	 summer	 or	
autumn,	short	and	recurrent	attacks	of	tumefaction	
and	pain	in	the	large	joints,	preceded	by	a	skin	rash.	
This	new	entity	was	named	Lyme	arthritis,	but	in	
the	following	years	a	multisystemic	disorder	was	
described,	named	Lyme	disease	and	later,	after	the	
discovery	of	the	etiological	agent,	Lyme	borreliosis	
(Burgdorfer	et al.,	1982).
In	1982	Burgdorferi	described	a	spirochete	of	
the	genus	Borrelia in	the	body	of	the	Ixodes	ticks,	
identified	as	the	etiological	agent	of	LB	and	named	
Borrelia burgdorferi.	 Due	 to	 the	 development	 of	
new	molecular	diagnostic	tools,	new	species	of	B. 
burgdorferi	were	described	in	the	following	years;	
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nowadays	19	different	species	are	identified	with	
different	geographical	distribution	(Franke	et al.,	
2013).
The	 genus	 Borrelia, a	 member	 of	 the	
spirochaete	 phylum,	 is	 divided	 into	 three	 major	
pathogenic	 groups	 of	 organisms,	 all	 transmitted	
by	 arthropods:	 B. burgdorferi	 sensu	 lato	 (the	
agent	 of	 LB),	 the	 relapsing	 fever	 borreliae,	 and	
the	 etiological	 agent	 of	 avian	 spirochaetosis,	
Borrelia anserina.	Members	of	the	genus	Borrelia 
have	 a	 very	 complex	 lifestyle	 as	 they	 are	 host	
associated	 spirochaetes	 that	 shuttle	 between	
haematophagous	arthropods	and	vertebrates.
2.1. Morphology, Shape and Membrane 
Structure
B. burgdorferi	 is	 a	 thin,	 elongated,	 motile,	
wave-like	 bacteria	 with	 the	 diameter	 of	 0.2	 μm	
and	length	of	15	μm.	The	bacterium	has	a	fragile	
outer	 membrane	 surrounding	 the	 protoplasmic	
cylinder.	This	cylinder	consists	of	a	peptidoglycan	
layer,	a	cytoplasmic	membrane	(inner	membrane)	
and	 the	 enclosed	 cytoplasmic	 contents	 (Johnson	
et al.,	 1984).	 7–11	 bipolar	 flagella	 are	 located	
in	 the	 periplasmic	 space	 attached	 to	 the	 poles	
and	 wrapped	 around	 the	 cell	 cylinder,	 giving	
the	 bacterium	 its	 characteristic	 flat	 wave	 shape	
(Motaleb	et al.,	2000).
2.1.1. Flagella, motility and chemotaxis
The	 periplasmic	 flagella,	 with	 an	 important	
role	 in	 morphology	 and	 motility,	 presents	 a	
filament,	a	hook	and	basal	body,	but	it	is	composed	
by	 two	 classes	 of	 proteins,	 instead	 of	 one	 as	 in	
other	 bacteria.	 The	 external	 flagellar	 protein	 Fla	
A	 is	 characteristic	 to	 the	 spirochetes,	 while	 Fla	
B	 presents	 homology	 to	 the	 flagellar	 proteins	 of	
other	bacteria.	A	feature	of	B. burgdorferi s.l.	is	its	
capacity	 to	swim	efficiently	 in	a	viscous	medium	
such	as	the	connective	tissue	where	other	bacteria	
are	slowed	down	or	immobilized.
2.1.2. Structure of the outer membrane
Since	 B. burgdorferi s.l.	 possesses	 both	 an	
outer	 membrane	 and	 a	 cytoplasmic	 membrane,	
the	 surface	 of	 this	 bacterium	 is	 analogous	
to	 enteric	 Gram-negative	 bacteria,	 but	 it	 has	
also	 several	 distinct	 features.	 For	 example,	 B. 
burgdorferi s.l.	has	a	high	abundance	of	membrane	
proteins	 covalently	 modified	 with	 lipids,	 has	 no	
lipopolysaccharide	 (LPS)	 but	 presents	 glycolipid	
antigens	 other	 than	 LPS.	 The	 B. burgdorferi 
outer	 membrane	 contains	 a	 low	 density	 of	
transmembrane-spanning	 proteins,	 being	 more	
susceptible	 to	 disruption	 by	 routine	 physical	
manipulations	 and	 to	 detergents	 compared	with	
Gram-negative	bacteria	(Bergström	et al.,	2002).
A. The lipoproteins
While	 the	 spirochete	 passes	 from	 the	
arthropod	 to	 the	 vertebrate,	 there	 are	 changes	
from	 an	 environment	 with	 no	 immune	 system	
based	on	antibodies	to	an	environment	with	high	
immunological	pressure.	To	persist	 in	 its	host,	B. 
burgdorferi	changes	its	surface	antigens.	More	than	
100	polypeptides	have	been	identified	in	the	outer	
membrane,	 but	 the	 sequencing	 of	B. burgdorferi 
genome	 has	 defined	 many	 other	 hypothetical	
lipoproteins.	 The	 most	 studied	 are	 the	 major	
outer surface proteins	(Osps).	Until	now	6	Osps	
have	 been	 characterised,	 OspA-F,	 exposed	 to	 the	
surface	and	fixed	through	a	lipidic	fraction	to	the	
external	membrane.
The	first	B. burgdorferi	gene	sequenced,	ospA, 
encodes	the	most	studied	protein	of	the	bacteria.	
OspA	is	expressed	by	the	spirochete	in	the	midgut	
of	unfed	tick	and	mediates	binding	to	the	intestinal	
epithelium.	OspA	and	OspB	are	implied	also	in	the	
adherence	 and	 penetration	 of	 the	 mammalian	
host	cell,	having	a	role	in	the	pathogenesis	of	LB.	
OspC	 is	 very	heterogenic,	 19	major	OspC	groups	
being	identified.	The	expression	of	OspA	and	OspB	
decreases	while	the	tick	is	feeding.	OspC	expression	
is	 induced	 36–48	 hours	 after	 the	 blood	 meal	
starts	and	mediates	the	escape	of	the	spirochaete	
from	 the	 tick	midgut	via	 the	haemolymph	 to	 the	
salivary	 glands	 from	 where	 it	 enters	 the	 new	
vertebrate	 host.	 OspD	 is	 another	 component	 of	
the	 outer	 membrane,	 while	 OspE	 and	 OspF	 are	
the	founding	members	of	a	protein	family	known	
as	 the	 OspEF-related	proteins	 (Erps),	 important	
for	 the	 virulence	 of	 B. burgdorferi	 (they	 bind	
complement	 factor	 H	 and	 inhibit	 complement	
activation).	Recombination	of	the	genes	encoding	
the	Erp	antigens	might	contribute	to	the	evasion	of	
the	mammalian	immune	response.
The decorin-binding proteins. Microbial	
adhesion	 and	 colonization	 of	 host	 tissues	 are	
important	events	in	the	bacterial	infection	process.	
Spirochaetes	 injected	 in	 the	 skin	 are	 found	
associated	with	collagen	fibres	in	the	extracellular	
matrix,	but	they	do	not	attach	directly	to	collagen	
but	 to	 decorin,	 a	 small	 proteoglycan.	 There	 are	
two	 borrelial-encoded	 adhesins	 that	 can	 bind	
to	 decorin,	 DbpA	 and	 DbpB	 (decorin-binding	
protein),	and	a	protein	that	can	bind	fibronectin-	
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BBK32.	 The	 interaction	 between	 BBK32	 and	
fibronectin	seems	to	be	an	important	pathogenic	
mechanism	 for	dissemination	 and	persistence	of	
B. burgdorferi	into	the	mammalian	host.
The vmp-like sequence, Vls, of B. 
burgdorferi s.l. Persistence	 of	 B. burgdorferi 
in	 the	 host	 can	 be	 achieved	 by	 a	 mechanism	
called	 antigenic	 variation;	 this	 mechanism	 has	
been	 studied	 for	 several	 years	 in	 relapsing	 fever	
borreliosis	 where	 new	 serotypes	 appear	 during	
relapses	due	to	a	change	in	surface	proteins	called	
variable	major	proteins	(Vmps).	In	B. burgdorferi 
s.s	a	linear	plasmid	was	found	to	have	a	sequence	
that	resembles	the	Vmp	system	in	B. hermsii -	vls 
locus.	 Recombination	 occurs	 in vivo as	 early	 as	
4	 days	 after	 experimental	 infection	 of	 mice	 but	
not	 in vitro,	 suggesting	 that	 the	mammalian	host	
provides	 the	 signal	 for	vls recombination	 (Zhang	
and	Norris,	1998).
RevA protein. Another	 surface	 expressed	
protein,	revA	is	expressed	in	the	mammalian	host	
due	 to	 increase	 in	 temperature	 (36ºC	 compared	
to	23ºC	 in	 ticks).	 The	 expression	of	RevA	 is	 also	
influenced	by	the	pH	(Caroll	et al.,	2001).	
The exported plasmid protein A	 (eppA)	
genes	 are	 only	 expressed	during	 infection	 in	 the	
mammalian	 host.	 The	widespread	 occurrence	 of	
eppA suggests	that	they	contribute	to	the	survival	
of	B. burgdorferi s.l.	in	nature,	and	possibly	to	the	
pathogenesis	of	LB	(Miller	et al.,	2000).
BmpA, BmpB, BmpC and BmpD	 constitute	
a	 family	 of	 homologous	 lipoproteins	 that	 are	
immunogenic	during	infection	in	vertebrate	hosts	
and	BmpA	(p39)	is	widely	used	in	the	diagnostic	
assays.	 BmpA	 activates	 the	 proinflammatory	
response	in	the	human	synovial	cells	(Yang	et al.,	
2008).
B. The porins
The	 permeability	 of	 the	 bacterial	 cell	
envelopes	 is	 the	 result	 of	 channel	 forming	
proteins	in	their	outer	membranes,	called	porins.	
Their	 function	 is	 to	 uptake	 the	 substances	 from	
the	 environment.	 Borrelia are	 limited	 in	 their	
metabolic	 and	 biosynthetic	 capacities	 and	
therefore	highly	dependent	on	nutrients	provided	
by	 their	hosts.	 	Tree	porins	have	been	described	in B. burgdorferi:	P13,	P66	(Oms66)	and	Oms	38/	
Dip	A.	DipA	protein,	which	exhibits	high	homology	
to	 the	 Oms38	 porin	 of	 relapsing	 fever	 Borrelia, 
presents	a	binding	site	specific	for	dicarboxylates	
which	 play	 important	 roles	 in	 the	 deficient	
metabolic	 and	 biosynthetic	 pathways	 of	Borrelia 
species	(Bergstrom	and	Zuckert,	2010).
C. The envelope-spanning protein 
complexes
Efflux systems and transporters. A	system	
called	BesC	was	identified	in	the	outer	membrane	
of	B. burgdorferi	with	properties	of	efflux	system	
and	export	through	membrane,	that	was	shown	to	
be	necessary	for	infection	in	mice	and	involved	in	
resistance	to	antibiotics.	This	efflux	system	has	a	
role	in	maintenance	of	cellular	homeostasis,	export	
of	exogenous	toxic	agents	and	survival	in	different	
host	environments	(Bunikis	et al.,	2008). Glucose	
is	 the	 major	 energy	 source	 for	 B. burgdorferi,	
involving	 several	 glucose	 transporters.	 Mannose	
host	 proteins	 are	 also	 a	 carbohydrate	 source	 for	
B. burgdorferi,	with	BB0408	and	BB0629	proteins	
suggested	 to	 be	 mannose	 transporters	 (von	
Lackum	and	Stevenson,	2005).
The oligopeptide permease (Opp A-1, 2 
and 3) are	used	for	transportation	of	peptides	into	
bacteria,	as	carbon	and	nitrogen	sources.
2.1.3. Blebs and cysts formation
B. burgdorferi s.l.	when	grown	on	stress	culture	
media	(antibiotics,	low	pH)	is	capable	of	producing	
extracellular	vesicles	(blebs),	that	contain	an	outer	
membrane,	while	 some	 also	 contain	 cytoplasmic	
membrane	(Radolf	et al.,	1994).	The	cyst	formation	
is	a	response	to	starvation	in	serum-free	medium	
and	 it	 implies	 changes	 in	 the	 cell	 integrity	 and	
form	 (Alban	 et al.,	 2000).	 It	 is	 a	 slow	 but	 active	
process	that	needs	protein	synthesis,	reversible	in	
50%	of	the	cases.	It	is	not	known	if	cyst	formation	
is	 implied	 in	 the	 persistence	 of	B. burgdorferi in 
the	 host,	 with	 a	 role	 in	 pathogenesis,	 immune	
evasion	and/or	resistance	to	antibiotics	(Brorson	
and	Brorson,	2006;	MacDonald,	2006).
2.2. The Genome and Genome Organization
The	 genetic	 organization	 of	 B. burgdorferi 
is	 unusual	 in	 the	 sense	 that	 it	 contains	 a	 small	
linear	 chromosome	 and	 21	 linear	 and	 circular	
plasmids	(most	bacterial	species	present	a	circular	
chromosome	and	 circular	plasmids).	Most	of	 the	
genome	 of	 the	 B. burgdorferi sensu	 stricto	 (s.s)	
strain	 B31	was	 published	 in	 1997	 (Fraser	 et al.,	
1997)	and	it	was	completed	in	2000	(Casjens	et al.,	
2000),	with	a	genome	size	of	1.52	Mbp:	910	725	
bp	on	the	linear	chromosome,	and	611	kbp	divided	
on	12	linear	(lp)	and	9	circular	plasmids	(cp),	and	
only	1283	genes	(compared	with	the	4405	genes	
present	 in	E. coli).	The	small	number	of	genes	 in	
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B. burgdorferi s.s	is	similar	to	the	number	of	genes	
in	the	related	spirochaete	Treponema pallidum; a	
number	 of	 genes	 encoding	 cellular	 biosynthetic	
enzymes	are	missing.	The	genome	of	14	strains	of	
B. burgdorferi	s.s.	was	completed	till	now	(Casjens	
et al.,	 2000;	 Schutzer	 et al.,	 2011),	 B. afzelii,	 B. 
garinii,	B. bissettii,	B. valaisiana	and	B. spielmanii 
(Schutzer	et al.,	2012).
2.3. B. burgdorferi Sensu Lato Complex
The	 19	 different	 genomic	 species	 of	 B. 
burgdorferi	 are	 classified	 based	 on	 their	
pathogenicity	to	humans.
2.3.1 Borrelia Species Pathogenic for 
Humans
B. burgdorferi	 sensu	stricto	(s.s).	 In	USA	 it	 is	
the	 only	 human	 pathogenic	 species,	 associated	
mainly	 to	 the	 musculoskeletal	 manifestations	 of	
LB,	 but	 also	 to	 the	 cutaneous	 and	 neurological	
manifestations.	In	Western	Europe	it	is	the	species	
mainly	isolated	from	arthritis	(Jaulhac	et al.,	2000).	
B. garinii.	 6	 serotypes	 have	 been	 described	
using	 monoclonal	 antibodies,	 out	 of	 which	
serotype	4	has	been	further	classified	as	a	different	
genospecies,	B. bavariensis	 (Margos	et al.,	2009).	
Concerning	 the	 organotropism	 of	 B. garinii,	 the	
neural	apparatus	is	the	main	target	(Wilske	et al.,	
1996),	but	rarely	B. garinii	has	been	isolated	from	
the	 synovial	 fluid	 (Fingerle	et al.,	 2008),	or	even	
from	the	cutaneous	lesions	of	ACA.
B. afzelii	 has	 an	 organotropis	 for	 skin,	 being	
the	 etiological	 agent	 mainly	 isolated	 from	 ACA	
(Lünemann	et al.,	 2001),	but	 it	was	also	 isolated	
from	the	cerebrospinal	fluid	(CSF)	or	joints.	
B. spielmanii.	 Until	 now	 it	 was	 isolated	 only	
from	the	EM	lesion	(Maraspin	et al.,	2006);	it	is	not	
clear	if	it	has	an	invasive	potential.
B. bissettii.	 In	 Europe	 it	 was	 rarely	 isolated	
from	the	EM	lesions	(Strle	et al.,	1997),	 from	the	
cardiac	valve	tissue	(Rudenko	et	2008),	 from	the	
serum	of	some	patients	with	 the	suspicion	of	LB	
(Rudenko	et.	2009),	or	 from	the	CSF	(Fingerle	et 
al.,	2008).
B. valaisiana.	 The	 pathogenic	 potential	
has	 rarely	 been	 described,	 being	 isolated	 by	
polymerase	 chain	 reaction	 (PCR)	 from	 skin	
(Rijpkema	et al.,	1997),	CSF	(Diza	et al.,	2004),	but	
it	was	not	isolated	by	cultivation	from	humans.
B. lusitaniae	has	been	isolated	from	the	skin	of	
a	portuguese	patient	(de	Franca	et al.,	2005).	
2.3.2. B. burgdorferi species with no proven 
human pathogenic potential
Eleven	 species	 have	 not	 been	 isolated	 from	
human	 so	 far:	 B. americana, B. andersonii, B. 
californiensis, B. carolinensis, B. japonica, B. tanukii, 
B. turdi, B. sinica, B. yangtze, B. kurtenbachii and B. 
finlandensis. 
Several	strains	of	unclear	phylogenetic	identity	
still	 need	 to	 be	 characterized	 and,	 if	 applicable,	
defined	as	new	species	(Franke	et al.,	2013).
2.3.3. B. burgdorferi species in Romania
B. afzelii,	 B. garinii,	 B. burgdorferi	 s.s.,	 B. 
valaisiana	 and	B. lusitaniae,	 species	with	 human	
pathogenical	 potential,	 have	 been	 identified	 in	
Romania	 in	 questing	 ticks	 (Kalmár	 et al.,	 2013)	
and	 in	 ticks	 collected	 from	 humans	 or	 animals	
(Briciu	et al.,	2014;	Ionita	et al.,	2013).
3. EPIDEMIOLOGY OF LB
3.1. Terminology 
A	vector	 tick	 is	able	 to	acquire	 the	pathogen	
during	 the	blood	meal,	maintains	 it	 through	one	
or	more	life	stages	and	passes	it	on	to	other	hosts	
when	 feeding	 again.	 In	 rare	 cases	 uninfected	
ticks	 can	 also	 acquire	 an	 infection	when	 feeding	
together	-	“co-feeding”-	with	infected	vector	ticks	
on	 a	 host,	 when	 mating,	 or	 the	 female	 infects	
transovarian	the	eggs.	
Tick	 hosts	 include	 all	 vertebrates	 that	 ticks	
feed	on	 in	nature.	A	 reservoir	host	must	 take	up	
a	 critical	 number	 of	 infectious	 agents	 during	 an	
infectious	 tick	 bite,	 must	 allow	 the	 pathogen	 to	
multiply	and	to	survive	in	its	body	and	must	allow	
the	 pathogen	 to	 find	 its	 way	 into	 other	 feeding	
ticks.	Non-reservoir	hosts	may	have	contact	with	
infected	ticks	and	may	or	may	not	develop	a	long-
lasting	infection	but	are	incapable	of	transmitting	
the	 infection	 to	 ticks.	Barrier	hosts	eliminate	 the	
infection	 in	 feeding	 ticks	 (zooprophylactic	 host),	
or	destroy	a	large	numbers	of	vector	ticks	because	
of	 efficient	 grooming	 or	 an	 acquired	 anti-tick	
immunity	(Kahl	et al.,	2002).
3.2. Vectors
Ticks	 are	 classified	 in	 the	 class	 Arachnida,	
subclass	Acari,	order	Parasitiformes,	and	suborder	
Ixodida.	 There	 are	 approximately	 878	 species,	
divided	into	four	families,	specifically	the	Argasidae	
(soft-bodied	 ticks),	 Ixodidae	 (hard-bodied	 ticks),	
Nutalliellidae,	 and	 Laelaptidae	 (Anderson	 JF,	
Magnarelli,	2008).	The	identification	of	ticks	uses	
a	holistic	system	(Estrada-Peña	et al.,	2004).
I. ricinus,	 the	 most	 important	 vector	 of	 B. 
burgdorferi	in	Europe,	has	a	life	cycle	between	2-6	
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years	 (it	 may	 vary	 from	 one	 habitat	 to	 another,	
influenced	 by	 climatic	 factors).	 The	 stages	 of	
development	 are	 represented	 by	 eggs,	 larva,	
nymphs	 and	 adults.	 I. persulcatus,	 the	 taiga	 tick	
is	the	vector	of	LB	in	the	southern	forest	zone	of	
Eurasia	 and	 some	 countries	 from	 Asia.	 I. ricinus 
and	 I. persulcatus	 overlap	 in	 far-eastern	 Europe.	
In	the	East	and	Center	of	North	America	the	main	
vectors	are	 I. scapularis ticks,	while	 I. pacificus is	
the	main	vector	in	the	Western	regions,	along	the	
Pacific	coast.	
B. burgdorferi	 s.l.,	 ingested	 with	 the	 blood	
meal,	colonize	the	mid-gut	of	the	tick	and	persist	
there	 along	 the	 different	 stages	 of	 development	
(trans-stadial	transmission).
3.3. Reservoir hosts
At	 least	 237	 animal	 species	 are	 implied	 in	
the	maintenance	 of	 I. ricinus	 population	 and	 are	
susceptible	to	be	reservoir	hosts	for	B. burgdorferi 
(Gern,	 2008).	 The	 xenodiagnosis,	 the	 only	 way	
to	 prove	 the	 infectivity	 of	 a	 vertebrate	 species,	
implies	 capturing	 and	 keeping	 in	 captivity	 the	
vertebrate.	 The	 reservoir	 host	 does	 not	 develop	
the	 disease,	 though	 minor	 symptoms	 may	 be	
present.	It	was	proved	that	rodents,	squirrels	and	
many	species	of	birds	are	reservoir	hosts.	Out	of	
the	 large	 mammals,	 the	 red	 foxes	 are	 reservoir	
hosts	 while	 large	 ungulates	 are	 not,	 but	 they	
contribute	indirectly	to	spirochetes	transmission,	
being	 hosts	 for	 ticks.	Migratory	 birds	 play	 a	 key	
role	 for	 LB	 distribution,	 since	 they	 are	 not	 only	
a	 reservoir	 for	 important	Borrelia	 spp.,	 but	 they	
also	 act	 as	 vehicles	 of	 infected	 ticks	 over	 long	
distances	(Rudenko	et al.,	2011).	The	description	
of	 new	 species	 of	 Borrelia in	 the	 last	 years	 has	
opened	a	new	domain	in	LB	ecology	that	suggests	
an	 association	 between	 certain	 genospecies	 and	
vertebrate	hosts.
4. B. BURGDORFERI INTERACTION 
WITH THE HOST
4.1. The Bite Site 
The	 tick	 creates	 a	 feeding	 pit	 with	 its	
mouthparts,	 using	 its	 hypostome	 (a	 barbed	
protuberance)	 as	 an	 anchor	 to	 the	 skin	 of	 the	
host,	 while	 bioactive	 agents	 from	 tick	 saliva	 are	
inoculated	into	the	skin	that	increase	B. burgdorferi 
chances	of	survival	(Radolf	et al.,	2012).	Proteins	
BbCRASPs	(B. burgdorferi	complement	regulator-
acquiring	 surface	 proteins)	 bind	 complement	
factor	 H	 and	 complement	 factor	 Hlike	 protein	
1.	 The	 first	 recognition	 of	 B. burgdorferi	 by	 the	
mammalian	 host	 is	 performed	 by	 the	 dendritic	
cells	and	macrophages	in	the	dermis.	Production	of	
cytokines	and	chemokines	by	neutrophils	results	
in	 the	 recruitment	 of	 additional	 inflammatory	
cells	to	the	bite	site.	B. burgdorferi	is	a	very	motile	
organism	that	may	escape	from	these	phagocytes	
(Moriarty	 et al.,	 2008);	 the	 spirochetes	 that	 do	
not	 escape	 are	 ingested	 and	 degraded	 into	 the	
phagosomes.	 Dendritic	 cells	 that	 have	 taken	 up	
spirochaetes	migrate	 to	 the	 lymph	nodes,	where	
they	present	processed	borrelial	antigens	to	T	cells	
and	B	cells.	Sensitized	T	cells	enter	the	circulation	
and	are	 recruited	 to	 the	 site	of	 infection.	Plasma	
cells	 secrete	 specific	 antibodies	 that	 can	 kill	 B. 
burgdorferi via	 complement-dependent	 and	
-independent	pathways.
4.2. Dissemination 
After	 a	 delay	 of	 up	 to	 2	 days,	B. burgdorferi 
begins	to	spread	to	distant	tissues.	To	disseminate,	
B. burgdorferi penetrates	 the	 matrix	 between	
cells	 and	 enters	 capillary	 beds.	 The	 spirochaete	
circumvents	 its	 inability	 to	 produce	 enzymes	
capable	 of	 digesting	 extracellular	 matrix	
components	 by	 appropriating	 host	 proteases,	
such	as	plasminogen	and	urokinase.	Egress	 from	
the	 circulation	 into	 tissues	 involves	 adhesion	 to	
vascular	 endothelium,	 followed	 by	 extravasation	
and	 expression	 of	 several	 adhesins	 that	mediate	
attachment	to	host	tissue.
4.3. Immune Response 
Both	the	innate	and	adaptive	immune	systems	
are	important	for	controlling	infection	during	the	
disseminated	phase,	as	mice	that	are	deficient	 in	
either	system	have	greater	bacterial	burdens	than	
wild-type	mice	(Weis	and	Bockenstedt,	2010).	The	
early	development	of	IgM	antibodies	independent	
of	 T	 cells	 is	 crucial	 for	 clearing	 the	 pathogen.	 T	
cell-dependent	 production	 of	 IgG	 by	 B	 cells	 is	
detectable	later	during	infection.
The	 need	 for	 serological	 tests	 to	 diagnose	
LB	has	 led	 to	 increased	research	on	 the	 immune	
response	during	B. burgdorferi	infection.	Flagellin	
B	 induces	 an	 early	 and	 intense	 response	 in	
antibodies,	 but	 has	 the	 disadvantage	 of	 cross-
reactivity	 with	 antigens	 of	 other	 bacteria.	 OspC	
induces	an	intense	immune	response	early	during	
infection	but	presents	a	heterogeneity	of	epitopes	
in	the	different	strains.	In	spite	of	its	role	in	antigenic	
variation,	 VlsE	 presents	 a	 highly	 immunogenic	
epitope	both	in	early	and	late	infection,	being	used	
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in	diagnostic	assays.	The	 IgM	and	 IgG	antibodies	
develop	slowly,	directed	 towards	a	 large	number	
of	proteins,	 as	 long	as	 infection	progresses.	 	The	
first	appear	the	antibodies	against	flagellin	(FlaB)	
and	p66,	followed,	as	B. burgdorferi	disseminates	
in	the	host,	by	antibodies	anti	OspC,	VlsE,	BBK32,	
Fla	A,	BmpA	(Wilske	et al.,	2007).
As	 almost	 half	 of	 the	 patients	 with	 EM	 do	
not	 present	 detectable	 antibodies,	 the	 lack	
of	 serological	 response	 does	 not	 exclude	 the	
diagnostic	 of	 EM	 (Dandache	 and	 Nadelman,	
2008).	 The	 existing	 data	 show	 an	 unpredictable	
response	in	antibodies	after	therapy,	variable	and	
not	correlated	with	clinical	evolution	(Glatz	et al.,	
2006).	The	persistence	of	IgM	and	IgG	antibodies	
has	been	described	10-20	years	after	infection	in	
asymptomatic	 patients	 (Kalish	 et al.,	 2001).	 It	 is	
assumed	that	the	sustained	positive	titers	indicate	
a	 long-term	 serologic	 memory	 that	 results	 from	
an	antigen-independent	polyclonal	activation	and	
differentiation	of	memory	B	cells.	 IgG	antibodies	
are	 found	 in	 high	 titers	 in	 patients	 with	 Lyme	
arthritis.
4.4. Immune Evasion 
Antigenic	 variation	 (VlsE)	 represents	 the	
main	mechanism	for	infection	in	mammalian	hosts	
(Bankhead	and	Chaconas,	2007).
Inhibition	 of	 complement	 cascade.	 Through	
BbCRASP	Borrelia binds	the	factor	H	proteins	and	
inhibits	 the	 binding	 of	 active	 C3b	 on	 its	 surface,	
protecting	 the	 bacterium	 against	 complement-
mediated	killing	(Kraiczy	et al.,	2001).
Protective	niches.	B. burgdorferi	may	survive	
for	at	least	one	year	in	the	tissue	of	experimentally	
infected	 mice,	 and	 due	 to	 its	 motility	 and	
invasiveness,	 it	may	penetrate	 in	 the	conjunctive	
tissue	 (Cabello	 et al.,	 2007).	 Though	 in	 vitro	
data	have	shown	that	B. burgdorferi	may	survive	
in	 intracellular	 niches	 (Girschick	 et al.,	 1996),	
in	 vivo	 spirochetes	 have	 been	 visualized	 only	
extracellular.	 New	 studies	 are	 needed	 to	 sustain	
the	role	of	niches	in	persistent	infection.
4.5. Persistence of Infection 
B. burgdorferi	 has	 the	 particularity	 of	 an	
extracellular	 pathogen	 that	 can	 cause	 persistent	
infection.	 Although	 there	 are	 many	 studies	 that	
suggest	the	role	of	immune	response	in	controlling	
infection,	 in	some	tissues,	 like	 joints,	 the	evasion	
of	 the	 immune	 response	 may	 be	 explained	 by	
the	 affinity	 of	 the	 spirochetes	 to	 the	 relatively	
avascular	 conjunctive	 tissue,	 that	 could	 impede	
the	penetration	of	phagocytes,	antibodies	or	even	
antibiotics.	The	persistence	of	 spirochetes	 in	 the	
vascular	 cutaneous	 tissue	 of	 immunocompetent	
mouse,	 visualizing	 the	 spirochetes	 without	 an	
associated	immune	infiltrate,	is	rather	difficult	to	
explain	(Hodzic	et al.,	2003).	An	explanation	could	
be	that	in	this	“dormant”	phase	the	spirochetes	are	
“seen”	as	harmless	by	the	immune	system,	possibly	
hiding	 under	 the	 host’s	 proteins	 or	 diminishing	
the	 antigen	 expression	 or	 proinflammatory	
molecules.	 Another	 explanation	 could	 be	 that	
spirochetes	 in	 the	 persistent	 phase	 of	 infection	
induce	changes	in	the	environment,	that	suppress	
the	recruitment	of	 inflammatory	cells.	Embers	et 
al.	(2012)	evaluated	the	primates	Rhesus macaque 
laboratory	infected	with	B. burgdorferi,	proving	by	
xenodiagnosis	post-therapeutical	persistence	of	B. 
burgdorferi.	The	persistence	of	B. burgdorferi	was	
proved	in	mice	and	dogs	(Straubinger	et al.,	1997;	
Hodzic	et al.,	2008),	but	no	Borrelia transmission	
to	 naive	 mice	 was	 achieved	 from	 ticks	 that	 fed	
on	 the	 infected	 mice.	 It	 was	 suggested	 that	
the	 persistent	 spirochetes	 are	 attenuated	 and	
noninfectious,	 representing	 a	 subpopulation	 of	
persisters	tolerant	to	antibiotics.	The	persistence	
of	B. burgdorferi	in	the	host	and	the	resistance	to	
antibiotics	was	suggested	by	some	authors	 to	be	
due	to	a	phenotypic	resistance	and	cyst	formation	
(Hunfeld	 et al.,	 2006;	 Sapi	 et al.,	 2011)	 or	 to	 a	
biofilm	(Sapi	et al.,	2012).	New	studies	are	needed	
to	 support	 these	 theories.	 The	 main	 questions	
regarding	 LB	 are	 that	 if	 the	 spirochetes	 remain	
pathogen	 after	 antibiotic	 therapy,	 if	 they	 will	
persist	for	a	long	time	or	if	they	will	be	cleared	by	
the	immune	response	of	the	host.
4.6. Reinfection
It	was	 shown	 that	 human	 immune	 response	
is	 not	 protective	 against	 reinfection	 in	 patients	
with	 EM	 treated	 with	 antibiotics.	 Reinfection,	
clinically	 manifested	 as	 different	 EM	 lesions	 at	
different	moments,	 is	 described	 in	 patients	with	
repeated	 tick	 bites,	 but	 seems	 to	 be	 extremely	
rare	 in	 patients	 with	 late	 manifestations	 (i.e.	
arthritis).	In	case	of	late	manifestations,	sustained	
immune	 response	 seems	 to	 offer	 a	 better	
protection	 against	 reinfection.	 It	 is	 not	 known	
yet	 if	 immunosupression	 increases	 the	 risk	 of	
reinfection.	 The	 variability	 of	 different	 strains	
may	explain	the	escape	from	the	existent	immune	
response	 after	 a	 previous	 infection,	 followed	 by	
reinfection	(Nadelman	and	Wormser,	2007).
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5. PATHOGENESIS
B. burgdorferi genome	 does	 not	 encode	 any	
known	toxins;	 tissue	damage,	and	hence	disease,	
is	 believed	 to	 be	 caused	 by	 multiplication,	
invasion,	persistence	of	B. burgdorferi	and	to	 the	
inflammatory	response	elicited	in	the	mammalian	
host.	 Data	 regarding	 the	 pathogenesis	 of	 LB	 has	
been	obtained	from	studies	on	mice,	seldom	on	dogs	
or	monkeys,	and	a	few	studies	on	human	cutaneous	
or	synovial	tissue,	cerebrospinal	or	synovial	liquid.	
The	 biopsies	 of	 EM	 lesion	 in	 humans	 showed	 T	
cells,	macrophages,	dendritic	cells	and	neutrophils,	
cytokines	and	chemokines	but	no	B	cells.	The	CSF	
analysis	 in	 patients	 with	 early	 neuroborreliosis	
showed	a	 lymphocytic	 infiltrate	with	moderately	
increased	proteinorachia	and	antibodies	against	B. 
burgdorferi.	The	lymphocytic	pleocytosis	is	caused	
by	the	lymphocytes	B,	as	B. garinii	may	stimulate	
the	 monocytes	 in	 vitro	 to	 produce	 CXCL13,	 the	
lymphocytes	B	chemoatractant.	The	levels	of	C1q,	
C4,	C3	and	C3a	are	 increased	 in	 the	CSF	but	not	
in	 the	 plasma,	 suggesting	 that	 the	 inflammatory	
response	is	localized	in	the	CSF	(Rupprecht	et al.,	
2007).
Lyme	arthritis	presents	in	two	clinical	forms:	
an	 acute	 arthritis,	 reproduced	 by	 the	 murine	
model	 and	 a	 prolonged	 arthritis	 that	 resembles	
rheumatoid	 arthritis	 (Steere	 and	 Angelis,	 2006).	
The	 synovial	 biopsies	 in	 nontreated	 patients	
showed	lymphocytic	infiltrates,	rare	macrophages,	
dendritic	 and	 plasmatic	 cells	 associated	
with	 spirochetes	 and	 antigen	 deposits	 in	 the	
perivascular	 space.	 The	 spontaneous	 remission	
of	an	acute	arthritis	episode	is	immune	mediated,	
but	the	spirochetes	may	persist	in	the	absence	of	
antibiotic	therapy	and	cause	recurrent	episodes	of	
arthritis.	10%	of	the	patients	with	Lyme	arthritis	
develop	 chronic	 synovitis.	 In	 studies	 from	 the	
‘80s,	 these	 patients	 were	 presenting	 arthritis	
>12	months	and	responded	to	antibiotic	 therapy	
when	 it	was	 initiated	(Steere	et al.,	1987).	 In	 the	
following	 years,	 a	 second	 group	 of	 patients	 was	
identified,	 to	whom	arthritis	was	not	responding	
to	 3	 months	 of	 antibiotic	 therapy	 (Steere	 and	
Angelis,	2006),	and	inflammation	persisted	in	the	
absence	of	B. burgdorferi.	These	patients	present	
high	levels	of	TNF	alpha,	IL-1	beta	and	IFN	gamma	
in	 the	 synovial	 liquid.	 Many	 theories	 have	 been	
proposed	to	explain	the	pathogenesis	of	refractory	
Lyme	 arthritis;	 the	 autoimmune	 theory	 is	 based	
on	 similarities	 between	 Lyme	 arthritis	 and	
rheumatoid	arthritis	 (the	presence	of	HLA-DRB1	
molecules)	(Steere	et al.,	2006).
Biopsies	from	the	first	cases	of	Lyme	carditis	
showed	myocardic	 infiltration	with	 lymphocytes,	
plasmatic	cells	and	macrophages.	Murine	carditis	
is	 characterized	 by	 bacterial	 infiltration	 of	 the	
conjunctive	tissue	around	the	aortic	valve	and	the	
aorta	at	the	heart	base;	the	leucocytic	infiltrate	has	
a	peak	on	the	15th	day	of	infection,	with	remission	
of	carditis	and	spirochetal	clearance	after	30	days	
(Barthold	et al.,	1991).
Pathogenesis	 research	 in	LB	has	passed	 into	
the	 genomic	 era	 and	 it	 is	 likely	 that	 functional	
genomics	will	shed	more	light	on	disease-inducing	
mechanisms	of	B. burgdorferi s.l.	in	the	near	future.
6. CONCLUSIONS
From	 the	 public	 health	 prospective,	 a	 better	
information	 on	 the	 etiology	 and	 epidemiology	
of	B. burgdorferi,	 its	 interaction	with	 the	 human	
host	and	disease	pathogenesis,	 	 represents	a	key	
factor	for	a	better	approach	to	Lyme	borreliosis	of	
medical	personnel.	
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